Minnesota Multiphasic Personality Inventory profiles were analysed in 55 patients with pseudoseizures (40 patients with pseudoseizures only-pure group, and 15 patients with both pseudoseizures and epilepsy-mixed group). For each of the 10 clinical scales, there were no significant differences between the groups in mean T-score values or the incidence of pathological scores (T-score of 70 or above). In 87.3% of cases in the entire sample (groups combined), at least one clinical scale was elevated in the pathological range. For the combined groups, scales having the highest mean values as well as highest incidence of pathological scores were Schizophrenia, Hysteria and Depression. The mean profile of the entire sample (n = 55) had a two-point code of 8-3 with Schizophrenia and Hysteria as proNe peaks. Application of three sets of published criteria for hysteria or conversion yielded markedly different results. This finding underscores the difficulty in evaluating the role of hysteria in pseudoseizures in the absence of a single standard. Mean values and the overall profile of this patient sample were remarkably similar to those found in two previous studies.
INTRODUCTION
Pseudoseizures are a common problem in neurology practice which can, on occasion, pose a significant diagnostic and therapeutic challenge. In this context, psychological testing is often applied in order to provide information aiding in diagnosis. The Minnesota.Multiphasic Personality Inventory (MMPI) is a well-known and wellstudied objective personality assessment tool that is often used for that purpose. Studies dealing with pseudoseizures and the MMPI have typically been organized around such questions as to whether or not there is a specific personality pattern evident on the MMPI that characterizes pseudoseizure patients and distinguishes them from patients with epilepsy'. In addition to trying to establish its value in differential diagnosis, various studies have asked whether pseudoseizures represent a form of hysteria'. Two of the largest published studies to date have yielded contradictory conclusions. Wilkus, Dodrill and Thompson compared patients with pseudoseizures to those with epilepsy2. They found that patients with pseudoseizures scored significantly higher than epileptics on the following scales of the MMPI: Hypochondriasis, Hysteria, Psychopathic deviate and Schizophrenia.
Their most striking finding, however, was that by applying a set of three criteria for evaluating the MMPI performance they could correctly classify 80-90% of their patients. They reported that there was a preponderance of profiles suggesting conversion hysteria in their pseudoseizure group. They concluded that 'possibly as many as 80% of our pseudoepileptic patients demonstrated conversion symptomatology in one form or anothe?. Vanderzant et al also compared pseudoepileptic patients to patients with epilepsf. They, however, found no significant differences between the groups with respect to mean T-scores on any of the MMPI scales. Most importantly, they did not find that the three rules proposed by Wilkus et al helped to differentiate a group of patients with pseudoseizures from a comparison group of epileptic patients with generalized tonic-clonic seizures (only 37% of the pseudoseizure patients were correctly classified). Vanderzant and col-2 D. Kalogjera-Sackellares & J.C. Sackellares leagues concluded that there was no characteristic MMPI profile specifically associated with pseudoseizures, nor was hysteria a characteristic form of psychopathology in that group3. In a subsequent study, Wilcus and Dodrill found that the applicability of their rules for defining a characteristic MMPI profile for patients with pseudoseizures depended upon the clinical symptomatology manifest during pseudoseizure attacks4. They concluded that differences in selection criteria accounted for the discrepancy between the findings of Vanderzant ef al and their earlier study. The difficulties in diagnosing psychogenic pseudoseizures are further compounded by the fact that a significant proportion of patients with pseudoseizures also have epilepsy. In the study by Vanderzant and coworkers3, MMPI profiles of patients with pseudoseizures without concomitant epilepsy were compared with MMPI profiles from a comparison group of patients with epilepsy. No significant differences were found between these groups. However, other authors have found significant differences between MMPI profiles obtained in patients with pseudoseizures and the profiles of patients with epilepsy'-'. It is likely that these differences in results reflect differences in criteria for subject selection and the comparison groups utilized. In this study, we examined the possibility that the presence of concomitant epilepsy would influence the MMPI profiles in patients with pseudoseizures.
In our present study, we investigated the MMPI profiles of a sample of 55 patients with pseudoseizures. Forty subjects had only evidence of pseudoseizures (the pure group), and 15 subjects had both pseudoseizures and epilepsy (the mixed group). The aims of our study were threefold:
(1) to compare the mean MMPI profiles of the pure and mixed groups, (2) to characterize the MMPI profiles with respect to the overall degree of psychopathology, to identify characteristic scale elevations, to define the profile in terms of a two-point code (i.e. two highest scales), and to establish the incidence of Conversion V pattern using various established criteria (to be described), (3) to establish whether the mean MMPI profile was robust, i.e. did different investigators, in different centres, and at different times obtain comparable data. to pseudoseizures was diagnosed in 15 of the 55 patients. Of these 15 patients with mixed pseudoseizures and epilepsy (mixed group), epileptic seizures were confirmed by ictal EEG-CCTV recordings in seven cases. In the remaining eight cases, the diagnosis of concurrent epileptic seizures was based upon clinical history and interictal EEG recordings. Forty patients were diagnosed as having pure pseudoseizures (pure group). In these cases, there was no evidence of concomitant or pre-existing epilepsy.
METHODS
The mean T-scores for each of the 10 clinical scales and three validity scales of the MMPI were computed for each of the two groups. In addition, for each group, the percentage of patients with T-scores in the abnormal range (70 or above) for each of the 10 clinical scales was determined. The two groups were compared with respect to the mean scores on each clinical scale and three validity scales using the analysis of variance. The groups were compared with respect to the incidence of abnormal scores on each clinical scale using the chi square statistic. Mean T-scores for the clinical and validity scales were also determined for the entire patient sample (combined mixed and pure groups). In addition, the incidence of abnormal scores for each MMPI clinical scale was established for the entire sample. The incidence of profiles meeting previously published criteria for hysteria or conversion (see Table 1 ) was determined for each of the two groups and for the sample as a whole. Finally, the results of this study were compared with results of two prior studies of the MMPI in patients with pseudoseizures.
RESULTS

Comparison of the pure and mixed groups
The pure and mixed groups were compared with respect to the mean T-scores for clinical and validity scales using ANOVA.
To reduce the chances of a type II error, an (Y level of P 5 0.1 was used. As Table 2 indicates, no significant differences between the groups were found. The pure and mixed groups were also compared with respect to the percentage of subjects showing elevations in the pathological range on each of the clinical scales. The pathological range was defined as a T-score equal to or exceeding 70. The x2 statistic was used to test for significance. To reduce the chances of a type II error, and (Y level of P I 0.1 was used. These results are summarized in Table 3 . As is evident from Table  3 , the pure and mixed groups did not show statistically significant differences with regard We also compared the pure and mixed groups with respect to the overall level of psychopathology. This was defined as percentage of cases in each group containing at least one clinical scale in the pathological range (T-score equal to or exceeding 70). Very comparable results were obtained again, for the two groups. In the pure group, 35 out of 40 cases (87.5%) had at least one pathological elevation on a clinical scale. In the mixed group, 13 out of 15 cases (86.6%) met this criterion of psychopathology.
In view of the similarity between the pure and mixed groups, as evidenced by the absence of statistically significant differences, we combined the groups and performed further MMPI analyses using the entire sample (n = 55).
MMPI characteristics of the entire sample (groups combined) With regard to the overall level of psychopathology, we found that as many as 48 out of 55 patients (87.3%) had at least one clinical scale elevation in the pathological range. We also computed the mean number of pathological elevations on a clinical scale per case. We found an average of 3.49 elevations per case in the overall sample (3.6 elevations per case in the pure group, and 3.2 per case in the mixed group). We next looked at the mean MMPI profile in terms of its two highest scale elevations known as the two-point code. A two-point code is important because it summarizes the profile in terms of its distinctive clinical characteristics. We found that our mean MMPI profile has a two point code of Marks and Seeman' All 3 of the following criteria must be met: 1. Hysteria and Hypochondriasis scales both have T-scores above 70. 2. Hysteria and Hypochondriasis scales both are 10 points higher than the Depression scale. 3. No other scales in the profile have elevations in the pathological range.
Wilkus, Dodrill and Thompson2
Any one of the following 3 rules are met: 1. Hysteria or Hypochondriasis scale has a T-score of 70 or above, and is one of the two highest points in the profile (Masculinity-femininity and Social Introversion scales are not considered). 2. Hysteria or Hypochondriasis scale scores of 80 or above, even if they are not among the two protile peaks. 3. Hysteria and Hypochondriasis scales both have a T-score exceeding 59, and both exceed the Depression scale by at least 10 points.
Duckworth and Anderson9
Both of the following criteria are met: 1. Hypochondriasis scale is at least 5 T-points greater than the Hysteria scale.
2. Hysteria and Hypochondriasis scales both exceed the Depression scale by at least 10 points. & J.C. Sackellares 83 which means that the highest scale is We studied the incidence of Conversion V Schizophrenia (8) and the next highest Hysteria pattern in our sample using three separate sets of (3). Further analysis of the profile revealed that criteria (those of Wilkus ef al*; Marks and pathological elevations (T score of 70 and higher) Seemans, and Duckworth and Anderson'). These were obtained on the following clinical scales: criteria are summarized in Table 1 . The incidence Schizophrenia, Hysteria and Depression scales.
of conversion using Wilkus and Dodrill's criteria Those were the highest elevations in the profile.
was quite high: as many as 52.7% of cases in the A similar picture emerged when we compared the entire sample, 60% in the pure group and 33.3% incidence of pathological elevations among in the mixed group. In sharp contrast, we found different clinical scales. Hysteria was elevated in that only 1.8% of our entire pseudoseizure the greatest percentage of cases (56.4%), sample satisfied Marks and Seeman's criteria for followed by Schizophrenia (52.7%), Depression Conversion hysteria (2.5% of the pure group and (49.1%), and Hypochondriasis (47.3%). There is 0% in the mixed group). Similarly, only 1.8% of a characteristic paired elevation between the our entire sample satisfied Duckworth's criteria Hysteria and Schizophrenia scales. The number for Conversion V (2.5% in the pure group and of cases having elevations of T equal to or exceed-0% in the mixed group). This illustrates dramatic ing 70 on both the Hysteria and Schizophrenia differences in conclusions about the role of scales was 36.3% for the entire sample. This hysteria in pseudoseizures, depending upon the pairing was observed in 40% of the cases in the particular criterion used to define conversion or pure group, and 26.6% of the mixed group. hysteria. In this study, we attempted to determine whether patients with both epilepsy and pseudoseizures would differ from patients with pseudoseizures only with respect to their MMPI profiles. However, no statistically significant differences were found in the mean T-scores on any of the 10 clinical scales or on the validity (L, K, or F) scales. Also, no significant differences were found with respect to the percentage of patients with abnormal scores on the 10 clinical scales. Of course, it is not possible to exclude the diagnosis of epilepsy with certainty in some cases. Thus, further studies with a larger sample should be undertaken to confirm the results of this analysis.
One of the most important findings which emerged in the present study has to do with the incidence of hysteria or conversion in pseudoseizures. Our results clearly illustrate how dramatically different interpretations might be derived, depending on whose criteria are used to define hysteria or conversion. Wilkus, Dodrill and Thompson's criteria' are clearly the most liberal and inclusive. When applied to our data, they identified 50-60% of our sample of pseudoseizure patients as showing some conversion symptomatology.
When the more stringent, classical criteria of Marks and Seeman' were applied, however, a strikingly different result was ob- tained. Only 1.8% of the profiles could be characterized as showing Conversion V pattern. The very recent criteria offered by Duckworth' in her textbook on the MMPI likewise classified only a small percentage of our cases (1.8%) as showing hysterical V. These remarkable discrepancies illustrate the importance of developing a standard set of criteria for characterizing an MMPI record as showing hysterical phenomena. In the absence of such a standard, the role of hysteria in pseudoseizures cannot be properly evaluated. Yet another reason why it is important to arrive at a standard definition of hysteria (or at least indicate clearly which definition was used to evaluate the data) has to do with the fact that historically, hysterical conversion has been assumed to play an important role in the pathogenesis of psychogenic pseudoseizures"'-'3. It should be noted in this context that the MMPI (psychometric) criteria for hysteria represent only one way of characterizing hysterical phenomena. Psychometric criteria should not be assumed to be equivalent to clinical hysteria.
Much of the literature regarding the application of MMPI rules in patients with pseudoseizures centres around the power of these rules in discriminating between patients with psychogenic seizures and those with epilepsy. This issue, and the influence of selection criteria on the diagnostic result, has been discussed elsewhere'-7,'4.'5 More recently, the utility of the MMPI-2 in distinguishing patients with pseudoseizures from those with epilepsy has been explored'6. The issue of the diagnostic power of the MMPI in distinguishing between patients with epileptic seizures and those with psychogenic pseudoseizures was not addressed by the present study. In contrast, we sought to explore the psychological issues in a group of patients with well-established diagnoses using the MMPI as a diagnostic tool. Thus, we did not include a group of epileptic patients for comparison.
The variability of the incidence of cases meeting the MMPI criteria described by Wilcus and Dodrill has received some discussion in the literature'-7,'4*15. This variability may result from the relatively small sample in any of the reported series. This limitation, in turn, is due to the practical difficulties of acquiring a large sample of well-defined cases. It is also possible that the reported differences result from differences in case selection or may be due to differences in the referral populations upon which these reports are based. However, given the strong similarities among the centres with respect to group statistics, as discussed below, this explanation is less likely.
Another important finding in the present study has to do with considerable similarity of mean MMPI profiles of patients with pseudoseizures across three different investigations: the present study and the studies by Wilkus ef al* and Vanderzant and co11eagues3. The mean scores on the clinical scales show some expected variation among the three studies compared. However, these predictable differences are overshadowed by the similarities, especially in terms of the overall shape and pattern of the profile. The shape and pattern of the' profile, in turn, are informative because they reveal important clinical characteristics, indeed they define the profile.
Comparing the three mean profiles, we find that Schizophrenia, Hysteria, Hypochondriasis and Depression are the most prominent scales in the profile (regardless of absolute elevations). Even more noteworthy is the fact that in all three studies, the mean profile has the same two-point code -83-(Schizophrenia and Hysteria are profile peaks). As noted earlier, a two-point code is an important descriptive index of the MMPI record and it summarizes the essential clinical properties of the profile.
It should be noted in this context, that a thorough understanding of the clinical characteristics of the present pseudoseizure sample can only be determined by analysing individual records. By the same token, the degree of similarity among the three samples can be fully determined only by an analysis and comparison of individual MMPI profiles. However, the similarities among the mean profiles in terms of the overall shape of the profile, characteristic profile elevations, and especially, the same two-point code, all suggest that there are important parallels present in the three studies which are not accidental or arbitrary since the samples stem from different centres and/or time periods.
One of the most intriguing findings in the present study is the joint elevation of Schizophrenia and Hysteria scales in about one third of the cases. These are two very different scales, and they reflect quite different clinical characteristics and personality and cognitive styles. For example, elevations on Hysteria are characteristically associated with conventional, even stereotyped thinking, whereas elevations on Schizoprenia may reflect (among other things) confused, disordered or unusual thinking".
One might further contrast the two scales by associating elevations on Hysteria with reliance on denial and repression as chief mechanisms of defense, whereas elevations on Schizophrenia might be conceptualized as a breakdown of repression and other defences, and, also impairment of cognitive control. Why these two scales should be jointly elevated in a sizable proportion of our cases is not clear. Exploring the meaning of this unusual association might provide clues as to the nature of pseudoseizures or the mechanisms whereby pseudoseizures are generated.
A related issue has to do with reasons why the Schizophrenia scale should be highest in the mean profile in the first place, and why it should be elevated in approximately half of all the records in the present study. This scale has a prominent place in the mean profile of not only our study, but the two other studies we used for comparison2*3. Thus, the finding cannot be dismissed as reflecting idiosyncratic properties of the present sample. Wilkus, Dodrill and Thompson' interpreted their findings on the Schizophrenia scale as reflecting confused thinking. Vanderzant et a13, in turn, attributed elevations on Schizophrenia to cerebral disturbance in some pseudoseizure patients. Both of these interpretations have some merit, although they do not enable us to deal with the fact that contradictory or seemingly contradictory scales are elevated together. Also, the notion of cerebral disturbance being responsible for elevations on the Schizophrenia scale does not account for the fact that our pure pseudoseizure group (i.e. without any evidence of epilepsy) had a very similar mean score on the Schizophrenia scale as our mixed group (patients with both pseudoseizures and epilepsy). Also, both the pure and mixed groups had a very comparable incidence of pathological elevations on the Schizophrenia scale (approximately 50% of the profiles). Again, these questions may require further research involving individual profiles.
In conclusion, how does the present study enable us to address the questions posed by the previous research? For example, is there a single characteristic MMPI profile? Clearly not. Nonetheless, the analysis of mean profiles and group data points to certain important parallels across different studies. These important parallels, however, contain seemingly incompatible elements, and the reason for their joint occurrence should be explored by further research.
